Page last updated: 2024-09-02

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Body Weight

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Body Weight in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busboom, JR; Dodson, MV; Du, M; Duarte, MS; Filho, SC; Gionbelli, MP; GuimarĂ£es, SE; Mezzomo, R; Paulino, PV; SerĂ£o, NV; Silva, LH1
Dalton, VS; Zavitsanou, K1
Lavie, G; Leker, RR; Ovadia, H; Teichner, A1
Ferrari, F; Giuliani, D; Ottani, A1
Lavie, G; Leker, RR; Ovadia, H; Shohami, E; Teichner, A1
Eisen, A; Feigenbaum, JJ; Mechoulam, R; Seltzer, Z; Zeltser, R1

Other Studies

6 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Body Weight

ArticleYear
Effects of pregnancy and feeding level on carcass and meat quality traits of Nellore cows.
    Meat science, 2013, Volume: 94, Issue:1

    Topics: Adipose Tissue; Animal Feed; Animals; Body Composition; Body Fluid Compartments; Body Weight; Caloric Restriction; Cattle; Diet; Dietary Fats; Dronabinol; Energy Intake; Female; Meat; Muscle, Skeletal; Pregnancy; Stress, Mechanical; Subcutaneous Fat

2013
Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210.
    Synapse (New York, N.Y.), 2010, Volume: 64, Issue:11

    Topics: Age Factors; Analgesics; Analysis of Variance; Animals; Animals, Newborn; Body Weight; Brain; Brain Mapping; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Male; Protein Binding; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Tissue Distribution; Tritium

2010
Combination of dexanabinol and tempol in focal cerebral ischemia: is there a ceiling effect?
    Experimental neurology, 2003, Volume: 182, Issue:2

    Topics: Animals; Behavior, Animal; Body Weight; Brain Ischemia; Cyclic N-Oxides; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Inbred SHR; Recovery of Function; Spin Labels; Treatment Outcome

2003
Effects of the cannabinoid receptor agonist, HU 210, on ingestive behaviour and body weight of rats.
    European journal of pharmacology, 2000, Mar-17, Volume: 391, Issue:3

    Topics: Animals; Body Weight; Cannabinoids; Drinking; Drinking Behavior; Dronabinol; Eating; Feeding Behavior; Male; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug

2000
Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia.
    Brain research, 2001, May-18, Volume: 901, Issue:1-2

    Topics: Animals; Body Weight; Brain Ischemia; Cardiovascular Physiological Phenomena; Cerebral Cortex; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Encephalitis; Free Radicals; Infarction, Middle Cerebral Artery; Male; Movement Disorders; Nerve Degeneration; Neurons; Neuroprotective Agents; Rats; Rats, Inbred SHR; Tetrazolium Salts

2001
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties.
    Pain, 1991, Volume: 47, Issue:1

    Topics: Animals; Behavior, Animal; Body Weight; Copper; Dronabinol; Drug Interactions; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nervous System Diseases; Pain; Pain Measurement; Rats; Receptors, N-Methyl-D-Aspartate

1991